Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Bullboard Posts
Comment by bilosellhion Jan 29, 2005 2:59pm
260 Views
Post# 8508320

RE: NEW clinical trial RESULTS reported in paper

RE: NEW clinical trial RESULTS reported in paperONE2DUMB if you bothered to read the 2nd paragraph of the first page of the paper (i know that might be asking too much) you would have realized it said "16 patients with incurable metastatic cancer were interviewed prior to being accepted into the phase I trial with a semi-structured expectations interview" that means these interviews were conducted BEFORE they were treated (that also means this paper has little to do with detailed results as many here misleadingly try to point out) under table 1, it lists the patient number (presumably in the order they were treated) and the days from interview till death - notice that patient 2 has the highest days from interview till death - which would seemingly corroborate that patient number represents the order they were treated. it is also suggestive that this report was written about 200 days after the date (nov 29, 2001) the last patient was enrolled (assumes they were interviewed a week before being treated). that would put the report date around may or june of 2002, which is reasonably consistent with the patient #2 being interviewed shortly after commencement of the trail in Jun 2000. so this report was written sometime in May/June 2002, submitted over 2 years later in Oct 2004 and accepted 3 months after submission. my question - what was this report doing sitting on a shelf for 2 years? and where are the detailed results of the actual trial? and why didn't/doesn't onc issue a press release updating the ongoing status of these patients? more questions than answers like usual.
Bullboard Posts